Want to see AU:IME full AI Analyst Report?
IME Stock Chart & Stats
AU$0.40
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.40
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.21 - AU$0.47
Previous CloseN/A
Volume202.98K
Average Volume (3M)41.77K
Market Cap
AU$16.86M
Enterprise ValueAU$18.89
Total Cash (Recent Filing)AU$3.30M
Total Debt (Recent Filing)AU$566.32K
Price to Earnings (P/E)―
Beta0.46
Next Earnings
Aug 31, 2026EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding54,395,714
10 Day Avg. Volume23,052
30 Day Avg. Volume41,775
Financial Highlights & Ratios
PEG Ratio1.98
Price to Book (P/B)1.29
Price to Sales (P/S)0.71
P/FCF Ratio83.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.02
Revenue Forecast (FY)AU$32.59M
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthRevenue accelerated to 10.0% in 2025 from 0.4% in 2024 and continues multi-year expansion. Sustained top-line growth indicates improving product adoption and market penetration, providing a durable foundation for scale and potential margin recovery if cost structure stabilizes.
Conservative Balance SheetDebt-to-equity fell to 0.04 in 2025 from 0.08 in 2024 and 0.14 in 2021, reflecting conservative leverage. Low debt affords financial flexibility to fund growth, withstand downturns, and avoid refinancing risk—structural strengths that support long-term investment choices and operational resilience.
Positive Cash Flow TurnaroundOperating cash flow of A$0.56M and free cash flow of A$0.24M in 2025 reversed prior negatives. Improved cash generation reduces dependence on external capital and supports reinvestment and operational stability; durability depends on sustaining conversion through business cycles.
Bears Say
Persistent Net LossesNet margin remained negative at -9.9% in 2025 with losses each year, producing a -18.2% ROE. Continued deficits erode equity, limit reinvestment from earnings, and constrain strategic flexibility; a sustained, demonstrable path to positive operating profitability is required for long-term stability.
Material Gross Margin DeclineGross margin dropped materially to 28.7% in 2025 from 41.5% in 2024, signaling pricing pressure or rising delivery costs. This weakens operating leverage and makes earnings recovery harder; unless the company fixes structural cost or pricing issues, margin headwinds will persist despite revenue growth.
Volatile Cash ConversionCash flow performance has been inconsistent—strong OCF in 2023, a decline in 2024, then a swing to positive in 2025. Such volatility undermines reliable funding for capex, R&D, or hiring, increases execution risk, and can force dependence on external financing during adverse periods.
ImExHS Limited News
IME FAQ
What was ImExHS Limited’s price range in the past 12 months?
ImExHS Limited lowest share price was AU$0.20 and its highest was AU$0.47 in the past 12 months.
What is ImExHS Limited’s market cap?
ImExHS Limited’s market cap is AU$16.86M.
When is ImExHS Limited’s upcoming earnings report date?
ImExHS Limited’s upcoming earnings report date is Aug 31, 2026 which is in 40 days.
How were ImExHS Limited’s earnings last quarter?
ImExHS Limited released its earnings results on Feb 26, 2026. The company reported AU$0.002 earnings per share for the quarter, beating the consensus estimate of -AU$0.015 by AU$0.017.
Is ImExHS Limited overvalued?
According to Wall Street analysts ImExHS Limited’s price is currently Overvalued.
Does ImExHS Limited pay dividends?
ImExHS Limited does not currently pay dividends.
What is ImExHS Limited’s EPS estimate?
ImExHS Limited’s EPS estimate is -0.05.
How many shares outstanding does ImExHS Limited have?
ImExHS Limited has 54,395,714 shares outstanding.
What happened to ImExHS Limited’s price movement after its last earnings report?
ImExHS Limited reported an EPS of AU$0.002 in its last earnings report, beating expectations of -AU$0.015. Following the earnings report the stock price went up 9.756%.
Which hedge fund is a major shareholder of ImExHS Limited?
Currently, no hedge funds are holding shares in AU:IME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ImExHS Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.55%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
8.81%
Trailing 12-Months
Company Description
ImExHS Limited
ImExHS Limited delivers cloud-powered medical imaging technologies to customers worldwide, including those in Australia. The firm specializes in the development and sale of modular imaging software systems, which encompass comprehensive information management platforms for disciplines such as radiology, cardiology, and pathology, alongside a robust picture archiving and communication system (PACS). Its principal software solutions include AQUILA for radiology, ALULA for pathology, and Antero for cardiology. Moreover, ImExHS offers STELLA.I, a suite of artificial intelligence tools hosted in the cloud, crafted to bolster diagnostic capabilities for medical professionals. The company further extends outsourced radiology and teleradiology services to hospitals and various other healthcare entities. Established in 2001, ImExHS Limited operates from its base in Mascot, Australia.
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Alcidion Group Limited
―
PainChek Ltd
―